| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing precisely tenecteplase 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| rekombinant koagulationsfaktor VIIa 60 000 IE, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely epoprostenol (as epoprostenol sodium) 500 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely rasburicase 1.5 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| tenekteplas 8 000 IE (40 mg), pulver till injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely alprostadil 10 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| somatropin (rbe) 1,6 milligram/spruta, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely etanercept 25 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Leuprorelin acetate 3.75 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely tenoxicam 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| rekombinant humant follikelstimulerande hormon alfa 37,5 IE, pulver till injektionsvätska, lösning, ampull |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely alprostadil 20 microgram/1 cartridge powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely etanercept 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| terlipressin 1 mg, pulver till injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| faktor VIII 1 000 IE + von Willebrand-faktor 2 200 IE, pulver till injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| rekombinant koagulationsfaktor IX 500 IE, pulver till injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| alprostadil 40 mikrogram, pulver till injektionsvätska, lösning, cylinderampull |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| immunglobulin anti-D (Rh) 1 500 IE, pulver till injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Alprostadil 40 microgram powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely sermorelin (as sermorelin acetate) 50 microgram/1 ampule powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Coagulation factor XIII 1250 unit powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| rekombinant koagulationsfaktor VIIa 240 000 IE, pulver till injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| urofollitropin 150 enheter, pulver till injektionsvätska, lösning, ampull |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Rifampicin 600 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Alprostadil 5 microgram powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely coagulation factor XIII 250 unit/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Alteplase 10 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely zoledronic acid 4 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely reteplase 10 unit/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| somatropin (rbe) 24 milligram/patron, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely glucagon hydrochloride 1 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| immunglobulin anti-D (Rh) 5 000 IE, pulver till injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely gonadorelin (as gonadorelin hydrochloride) 100 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Basiliximab 10 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| rekombinant koagulationsfaktor IX 1 000 IE, pulver till injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| immunglobulin anti-D (Rh) 600 IE, pulver till injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely sodium fusidate 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely valproate sodium 400 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| peginterferon alfa-2b 120 mikrogram, pulver till injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| antihemofilifaktorpreparat 1 000 IE, pulver till injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Basiliximab 20 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| somatropin (rbe) 200 mikrogram/spruta, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| antihemofilifaktorpreparat 1 500 IE, pulver till injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely carmustine 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| somatropin (rbe) 400 mikrogram/spruta, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| antihemofilifaktorpreparat 500 IE, pulver till injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely cetrorelix (as cetrorelix acetate) 250 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| somatropin (rbe) 600 mikrogram/spruta, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely vecuronium bromide 10 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely certolizumab pegol 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Cetrorelix (as cetrorelix acetate) 3 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| somatropin (rbe) 4 milligram/injektionsflaska, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| koriongonadotropin alfa 10 000 IE, pulver till injektionsvätska, lösning, ampull |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Interferon alfa-2b 1 million unit powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| somatropin (rbe) 6 milligram/patron, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Human alpha1 proteinase inhibitor 1 g powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| koriongonadotropin alfa 1 500 IE, pulver till injektionsvätska, lösning, ampull |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| somatropin (rbe) 800 mikrogram/spruta, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| humant alfa-1-antitrypsin 500 mg, pulver till injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| koriongonadotropin alfa 2 000 IE, pulver till injektionsvätska, lösning, ampull |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely lenograstim 13.4 million unit/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely alprostadil 10 microgram/1 cartridge powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| somatropin (rbe) 1,2 milligram/spruta, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| rekombinant koagulationsfaktor VIIa 120 000 IE, pulver till injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| koriongonadotropin alfa 5 000 IE, pulver till injektionsvätska, lösning, ampull |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Ixabepilone 15 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely disodium pamidronate 15 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| somatropin (rbe) 3 IE (1 mg), pulver till injektionsvätska, lösning, förfylld spruta |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| somatropin (rbe) 1,4 milligram/spruta, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Leuprorelin acetate 11.25 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Disodium pamidronate 90 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Deferoxamine mesilate 2 g powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| somatropin (rbe) 1,3 milligram/injektionsflaska, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| rekombinant koagulationsfaktor IX 250 IE, pulver till injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| naltrexonmikrosfärer 380 mg, pulver till injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Deferoxamine mesilate 500 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely omeprazole (as omeprazole sodium) 40 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Alprostadil 20 microgram powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| somatropin (rbe) 1,8 milligram/spruta, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| somatropin 1,5 mg, pulver till injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Epoprostenol (as epoprostenol sodium) 1.5 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely palivizumab 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| hydroxokobalamin 2,5 g, pulver till injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| somatropin (rbe) 2 milligram/spruta, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| urofollitropin 75 IE, pulver till injektionsvätska, lösning, ampull |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| somatropin (rbe) 5,8 mg, pulver till injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| torkad faktor IX-fraktion, upphettad, 600 IE, pulver till injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Palivizumab 50 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| lenograstim 263 mikrogram, pulver till injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| abobotulinumtoxin A 500 enheter/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| faktor IX 500 IE, pulver till injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| faktor IX 1 000 IE, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| somatropin (rbe) 16 IE (5,33 mg), pulver för beredning av injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Fosaprepitant (as fosaprepitant dimeglumine) 115 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Aciclovir (as aciclovir sodium) 250 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Amphotericin B 50 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Aciclovir (as aciclovir sodium) 500 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely clarithromycin 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Amifostine 500 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely drotrecogin alfa 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Amifostine 375 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|